| PERIOD ENDING | 31-Dec-04 | 31-Dec-03 | 31-Dec-02 | | Total Revenue | 3,047 | 1,486 |
-
| | Cost of Revenue | 1,900 | 1,132 |
-
| | | Gross Profit | 1,146 | 354 |
-
| | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,148 | 464 | 5 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (1) | (110) | (5) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | 40 |
-
| | Earnings Before Interest And Taxes | (0) | (70) | (5) | | Interest Expense | 30 | 15 |
-
| | Income Before Tax | (31) | (84) | (5) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (31) | (84) | (5) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (31) | (84) | (5) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($31) | ($84) | ($5) |
|
0.28% Nasdaq 0.00%
Income Statement
